We describe the epidemiology of invasive Haemophilus influenzae disease during 2007–2014 in 12 European countries and assess overall H. influenzae disease trends by serotype and patient age. Mean annual notification rate was 0.6 cases/100,000 population, with an increasing annual trend of 3.3% (95% CI 2.3% to 4.3%). The notification rate was highest for patients 20 years of age. Serotype f cases showed an increasing trend among persons >60 years of age. Serotype b cases showed decreasing trends among persons 1–5 months, 1–4 years, and >40 years of age. Sustained success of routine H. influenzae serotype b vaccination is evident. Surveillance systems must adopt a broad focus for invasive H. influenzae disease. Increasing reports of NTHi, par...
Background. Haemophilus influenzae is a human-restricted pathogen that forms part of the normal naso...
Background: Haemophilus influenzae type b (Hib) vaccination led to a significant decrease in inva...
Background.Following Haemophilus influenzae serotype b (Hib) conjugate vaccine introduction in the 1...
European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenz...
We describe the epidemiology of invasive Haemophilus influenzae disease during 2007-2014 in 12 Europ...
An international collaboration was established in 1996 to monitor the impact of routine Haemophilus ...
BackgroundFollowing Haemophilus influenzae serotype b (Hib) conjugate vaccine introduction in the 19...
European Union Invasive Bacterial Infection Surveillance participants: Paula Lavado (Departamento de...
Historically, Haemophilus influenzae (Hi) serotype b (Hib) caused most invasive Haemophilus infectio...
Following the introduction of vaccination against Haemophilus influenzae type b (Hib), cases of inva...
We analyzed national Haemophilus influenzae (Hi) surveillance data from 1994 and 1995 to describe th...
AbstractHistorically, Haemophilus influenzae (Hi) serotype b (Hib) caused most invasive Haemophilus ...
Background. The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine into n...
What is the current status of Haemophilus influenzae as an agent of invasive infection in Sweden? H....
OBJECTIVE: To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 1...
Background. Haemophilus influenzae is a human-restricted pathogen that forms part of the normal naso...
Background: Haemophilus influenzae type b (Hib) vaccination led to a significant decrease in inva...
Background.Following Haemophilus influenzae serotype b (Hib) conjugate vaccine introduction in the 1...
European Centre for Disease Prevention and Control Country Experts for Invasive Haemophilus influenz...
We describe the epidemiology of invasive Haemophilus influenzae disease during 2007-2014 in 12 Europ...
An international collaboration was established in 1996 to monitor the impact of routine Haemophilus ...
BackgroundFollowing Haemophilus influenzae serotype b (Hib) conjugate vaccine introduction in the 19...
European Union Invasive Bacterial Infection Surveillance participants: Paula Lavado (Departamento de...
Historically, Haemophilus influenzae (Hi) serotype b (Hib) caused most invasive Haemophilus infectio...
Following the introduction of vaccination against Haemophilus influenzae type b (Hib), cases of inva...
We analyzed national Haemophilus influenzae (Hi) surveillance data from 1994 and 1995 to describe th...
AbstractHistorically, Haemophilus influenzae (Hi) serotype b (Hib) caused most invasive Haemophilus ...
Background. The introduction of the Haemophilus influenzae serotype b (Hib) conjugate vaccine into n...
What is the current status of Haemophilus influenzae as an agent of invasive infection in Sweden? H....
OBJECTIVE: To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 1...
Background. Haemophilus influenzae is a human-restricted pathogen that forms part of the normal naso...
Background: Haemophilus influenzae type b (Hib) vaccination led to a significant decrease in inva...
Background.Following Haemophilus influenzae serotype b (Hib) conjugate vaccine introduction in the 1...